About Us
About Us
Ilios Santé GmbH is a GDP-certified (good distribution practice) pharmaceutical wholesaler founded in 2018 with the permission to import and trade medicinal products including narcotic drugs.
With its headquarters in Frankfurt am Main, Ilios Santé GmbH pursues the goal of establishing an international distribution network, starting with Germany as the world’s largest distribution market. Through careful selection of EU-GMP (good manufacturing practice for pharmaceuticals) certified partners in the areas of cultivation, production and logistics, we offer high quality products exclusively for our customers. The safe medical care of patients is the focus of our strategy development.
In addition to distribution, Ilios Santé GmbH has a strong focus on educating doctors, pharmacists and other industry-specific staff regarding the mode of action and availability of cannabinoid-containing medical products. The goal is to demonstrate the therapeutic benefits of medical cannabis as an alternative medicine and to break the stigma of the industry.
Our distribution network
With its headquarters in Frankfurt am Main, Ilios Santé GmbH pursues the goal of establishing an international distribution network, starting with Germany as the world’s largest sales market. Through carefully selected EU-GMP (Good Manufacturing Practice for Medicines) certified partners in the fields of cultivation, production and logistics, we offer high quality products exclusively for our customers. The safe medical care of patients is the focus of our strategy development.
Informing doctors and pharmacists
In addition to sales, Ilios Santé GmbH has a strong focus on educating doctors, pharmacists and other industry-specific staff regarding the mode of action and availability of cannabinoid-containing medical products. The goal is to demonstrate the therapeutic benefits of medical cannabis as an alternative medicine and to break the stigma of the industry.
Informing doctors and pharmacists
In addition to sales, Ilios Santé GmbH has a strong focus on educating doctors, pharmacists and other industry-specific staff regarding the mode of action and availability of cannabinoid-containing medical products. The goal is to demonstrate the therapeutic benefits of medical cannabis as an alternative medicine and to break the stigma of the industry.
